ERShares In The News
Filter Media
Recent Media
XOVR SpaceX Investment Gained $183M+ in Q2
The ERShares Private-Public Crossover ETF (NASDAQ: XOVR) recorded more than $183 million in unrealized appreciation...
Investors turn up the heat with $1.9bn raised in FinTech this week
Across the 19 deals reported on by FinTech Global this week, there was a grand...
After SpaceX, XOVR ETF Bets $30 Million on Kalshi as Prediction Markets Heat Up
The ERShares Private-Public Crossover ETF (NASDAQ:XOVR) has invested $30 million in Kalshi, making the federally...
XOVR Expands Private Market Strategy with $30 Million Investment in Kalshi
XOVR, the first ETF** to provide access to private equity exposure through a private-public crossover...
XOVR pours $30m into prediction market firm Kalshi
ERShares, adviser to the Nasdaq-listed ERShares Private-Public Crossover ETF (XOVR), has committed $30m to Kalshi,...
XOVR Expands Private Market Strategy with $30 Million Investment in Kalshi
XOVR, the first ETF** to provide access to private equity exposure through a private-public crossover...
Joel Shulman on Bloomberg TV: XOVR, SpaceX Exposure & the Private-Public Crossover ETF
Joel Shulman, Founder & CIO of ERShares, joined Bloomberg TV to discuss SpaceX, Elon Musk,...
After SpaceX, ETF XOVR taps into prediction market demand with $30 million Kalshi investment
ERShares’ Private-Public Crossover ETF (Ticker: XOVR) has made a $30 million investment in Kalshi, the...
EXCLUSIVE: SpaceX Sparked New ETF Race for Private Market Access; ‘Passive Funds Are Buying at $1.75T What We Bought Years Earlier,’ Says ERShares CIO
Space Exploration Technologies Corp’s (NASDAQ:SPCX) record-breaking rise from IPO to the Nasdaq-100 in just 15...
Past performance is no guarantee of future results. Please refer to the following disclosures:
The hyperlinks and website references on this page may forward you to third-party websites. All descriptions of, reference to, or links to other products, publications, or services do not constitute an endorsement by ERShares unless expressly stated by ERShares. The information, products, and sites accessible through this page have not necessarily been reviewed by ERShares and are provided or maintained by the third parties over whom ERShares does not exercise control. ERShares does not claim any responsibility for the content, accuracy, or quality of the information, products, and/or services provided by or advertised on these third-party websites. ERShares reserves the right to terminate any hyperlink at any time without notice.